Capacidad diagnóstica del antígeno carcinoembrionario

Locker, 2006, ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer, J Clin Oncol, 24, 5313, 10.1200/JCO.2006.08.2644

Thomson, 1969, The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system, Proc Natl Acad Sci USA, 64, 161, 10.1073/pnas.64.1.161

Fletcher, 1986, Carcinoembryonic antigen, Ann Intern Med, 104, 66, 10.7326/0003-4819-104-1-66

Bresalier RS. Neoplasias malignas del intestino grueso. En: Friedman LS, Sleisenger MH, editores. Sleisenger & Fordtran Enfermedades Gastrointestinales y Hepáticas. 7a edición. Buenos Aires: Editorial Médica Panamericana;2004, p. 2400

Duffy, 2003, Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM guidelines), Eur J Cancer, 39, 718, 10.1016/S0959-8049(02)00811-0

Wanebo, 1978, Preoperative carcinoembryonic antigen level as a prognostic indicador in colorectal cancer, N Engl J Med, 299, 448, 10.1056/NEJM197808312990904

Anonymous, 1981, Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement, Lancet, 282, 373

Ntaios, 2009, An audit of tumour marker utilization in Greece, Eur J Intern Med, 20, e66, 10.1016/j.ejim.2008.07.026

Sturgeon, 2009, Serum tumour markers: how to order and interpret them, BMJ, 339, b3527, 10.1136/bmj.b3527

Ficha técnica CEA para inmunoanalizador cobas® modelo e 411 de Roche® (Roche Diagnostics GMBH, Sanfhofer Strasse 116, D-68305 Mannheim (Alemania).

Molina, 1994, Marcadores tumorales, teoría o realidad, Med Clin (Barc), 102, 189

Quality requirements and control: EGTM recommendations. European Group on Tumour Markers. Anticancer Res. 1999;19:2791-4

Fernández Suárez, 2007, Marcadores tumorales serológicos, Química Clínica, 26, 77

Barker, 2007, Cancer biomarkers

Sturgeon, 2002, Practice guidelines for tumour marker use in the clinic, Clin Chem, 48, 1151, 10.1093/clinchem/48.8.1151

Wysocki, 1987, Carcinoembryonic antigen, alphafetoprotein and alpha and beta subunits of human chorionic gonadotropin in plasma of chidren with acute leukaemia, Acta Paediatr Hunf, 28, 119

Ruibal Morell, 1992, CEA serum levels in non-neoplastic disease, Int J Biol Markers, 7, 160, 10.1177/172460089200700307

Lopez, 1996, Prevalence of abnormal levels of serum tumor markers in elderly people, Age ageing, 25, 45, 10.1093/ageing/25.1.45

Scapa, 1997, The effect of colonoscopy on tumor markers, Surg Laparoscop Endosc, 7, 477, 10.1097/00019509-199712000-00009

Bertolini, 2005, Serum concentration of some tumor markers in renal failure, Resenti Prog Med, 96, 221

Collazos, 1992, Evaluation of the behaviour of carcinoembryonic antigen in cirrhotic patients, Int Biol Markers, 7, 244, 10.1177/172460089200700408

Sekine, 1993, Rhabdomyolisis and acute renal failure in a patient with hypothyroidism, Intern Med, 32, 269, 10.2169/internalmedicine.32.269

Kawaguchi, 2010, Elevation of serum carcinoembryonic antigen level in a patient with hypothyroidism after radiation therapy for cervical esophageal cancer, Int J Clin Oncol, 15, 104, 10.1007/s10147-009-0005-5

Kawashima, 1982, Increase of serum carcinoembrionic antigen in hypothyroidism, Rinsho Byori, 30, 903

Gold, 1965, Demonstration of tumor-specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques, J Exp Med, 121, 439, 10.1084/jem.121.3.439

Fleisher, 1965, Serum creatine kinase, lactic dehydrogenase, and glutamic-oxalacetic transaminase in thyroid diseases and pregnancy, Mayo Clin Proc, 40, 300

Bertola, 2004, Elevated concentration of serum carcinoembryonic antigen in hypothyroidism, Recenti Prog Med, 95, 204

Takahashi, 2007, Transient elevation of serum tumor markers in a patient with hypothyroidism, Am J Med Sci, 333, 387, 10.1097/MAJ.0b013e318065b023

Park, 2014, Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases, Gut Liver, 8, 58, 10.5009/gnl.2014.8.1.58